New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
New research may hold key to better treatments for aggressive brain cancer

New research may hold key to better treatments for aggressive brain cancer

by Spectrum HealthPrakash Chinnaiyan, M.D., a physician scientist in the Department of Radiation Oncology at Corewell Health in Southeast, Mich. Credit: Elizabeth Debeliso, Corewell HealthFor decades,
Oncology January 13,2024
New research may hold key to better treatments for aggressive brain cancer

New research may hold key to better treatments for aggressive brain cancer

by Spectrum HealthPrakash Chinnaiyan, M.D., a physician scientist in the Department of Radiation Oncology at Corewell Health in Southeast, Mich. Credit: Elizabeth Debeliso, Corewell HealthFor decades,
Oncology January 13,2024
Maternal depressive symptoms linked to slower fetal growth

Maternal depressive symptoms linked to slower fetal growth

by Elana GotkineMaternal depressive symptoms are associated with slower fetal growth rate in the critical rapid growth stage (CRGS) before delivery, according to a study published online Dec. 4 in&nbs
OB & GYN January 13,2024
Maternal depressive symptoms linked to slower fetal growth

Maternal depressive symptoms linked to slower fetal growth

by Elana GotkineMaternal depressive symptoms are associated with slower fetal growth rate in the critical rapid growth stage (CRGS) before delivery, according to a study published online Dec. 4 in&nbs
OB & GYN January 13,2024
Scientists shed light on mysteries associated with infertility

Scientists shed light on mysteries associated with infertility

by Kitta MacPherson,Rutgers UniversitySchematic depicting the distinct processes of meiosis I cytokinesis in oocytes and mitotic cytokinesis. Question marks refer to unknown biology in oocytes.
OB & GYN January 13,2024
Scientists shed light on mysteries associated with infertility

Scientists shed light on mysteries associated with infertility

by Kitta MacPherson,Rutgers UniversitySchematic depicting the distinct processes of meiosis I cytokinesis in oocytes and mitotic cytokinesis. Question marks refer to unknown biology in oocytes.
OB & GYN January 13,2024
New pancreatic cancer research could boost survival rates

New pancreatic cancer research could boost survival rates

byCU Anschutz Medical CampusGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.04.001A unique treatment combining radiation and immunotherapy can eradicate pancr
Oncology January 13,2024
New pancreatic cancer research could boost survival rates

New pancreatic cancer research could boost survival rates

byCU Anschutz Medical CampusGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.04.001A unique treatment combining radiation and immunotherapy can eradicate pancr
Oncology January 13,2024
Team uncovers why maternal diabetes predisposes babies to heart defects

Team uncovers why maternal diabetes predisposes babies to heart defects

byGladstone InstitutesIntegrated analysis of scRNA-seq and scATAC-seq reveals highly selective chromatin accessibility alterations in PGDM.a, Strategy for the in vivo PGDM model after trea
OB & GYN January 13,2024
Team uncovers why maternal diabetes predisposes babies to heart defects

Team uncovers why maternal diabetes predisposes babies to heart defects

byGladstone InstitutesIntegrated analysis of scRNA-seq and scATAC-seq reveals highly selective chromatin accessibility alterations in PGDM.a, Strategy for the in vivo PGDM model after trea
OB & GYN January 13,2024
Rise of microplastics discovered in placentas of Hawaiʻi mothers

Rise of microplastics discovered in placentas of Hawaiʻi mothers

byUniversity of Hawaii at ManoaIdentification of extracted MP by Raman spectroscopy analysis. Credit:Environment International(2023). DOI: 10.1016/j.envint.2023.108220A placenta (com
OB & GYN January 13,2024
Rise of microplastics discovered in placentas of Hawaiʻi mothers

Rise of microplastics discovered in placentas of Hawaiʻi mothers

byUniversity of Hawaii at ManoaIdentification of extracted MP by Raman spectroscopy analysis. Credit:Environment International(2023). DOI: 10.1016/j.envint.2023.108220A placenta (com
OB & GYN January 13,2024
New method eradicates deadly brain tumors by 'starving' them of energy source

New method eradicates deadly brain tumors by 'starving' them of energy source

byTel Aviv UniversityDr. Lior Mayo and students. Credit: Tel Aviv UniversityA groundbreaking study at Tel Aviv University effectively eradicated glioblastoma, a highly lethal type of brain cance
Oncology January 13,2024
New method eradicates deadly brain tumors by 'starving' them of energy source

New method eradicates deadly brain tumors by 'starving' them of energy source

byTel Aviv UniversityDr. Lior Mayo and students. Credit: Tel Aviv UniversityA groundbreaking study at Tel Aviv University effectively eradicated glioblastoma, a highly lethal type of brain cance
Oncology January 13,2024
New study addresses colorectal cancer disparities in Black communities

New study addresses colorectal cancer disparities in Black communities

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA new University of Kentucky Markey Cancer Center study highlights the need for increased outreach and education to red
Oncology January 13,2024
New study addresses colorectal cancer disparities in Black communities

New study addresses colorectal cancer disparities in Black communities

by Elizabeth Chapin,University of KentuckyCredit: Pixabay/CC0 Public DomainA new University of Kentucky Markey Cancer Center study highlights the need for increased outreach and education to red
Oncology January 13,2024
Newly developed gene classifier identifies risk of pre-breast cancer progression

Newly developed gene classifier identifies risk of pre-breast cancer progression

byDuke University Medical CenterCohorts and methods outline. Two retrospective study cohorts were generated, consisting of ductal carcinoma in situ (DCIS) patients with either a subsequent ipsil
Oncology January 13,2024
Newly developed gene classifier identifies risk of pre-breast cancer progression

Newly developed gene classifier identifies risk of pre-breast cancer progression

byDuke University Medical CenterCohorts and methods outline. Two retrospective study cohorts were generated, consisting of ductal carcinoma in situ (DCIS) patients with either a subsequent ipsil
Oncology January 13,2024
Novel theranostic agent targets multiple cancer types

Novel theranostic agent targets multiple cancer types

by Society of Nuclear Medicine and Molecular ImagingCredit: CC0 Public DomainA newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake, sustained tumor retention
Oncology January 13,2024
Novel theranostic agent targets multiple cancer types

Novel theranostic agent targets multiple cancer types

by Society of Nuclear Medicine and Molecular ImagingCredit: CC0 Public DomainA newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake, sustained tumor retention
Oncology January 13,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com